2- The fluctuations in plasma drug concentration are minimized and side effect associates with concentration are also minimized.
3- Complete absorption of drug from the floating formulation is expected even at alkaline pH of intestine. The dissolution occurs in gastric fluid and after emptying of the stomach contents the dissolved drug is available for absorption in small intestine.
4- Because of site‐specific absorption from the upper part of the GIT, Drugs that have poor bioavailability are potential candidates to be formulated as floating drug delivery systems, thereby maximizing their absorption.
5- FDDS improves patient’s compliance by reducing dosing frequency.
6- Better therapeutic effect achieved from short half-life drugs.
7- Because
3- Complete absorption of drug from the floating formulation is expected even at alkaline pH of intestine. The dissolution occurs in gastric fluid and after emptying of the stomach contents the dissolved drug is available for absorption in small intestine.
4- Because of site‐specific absorption from the upper part of the GIT, Drugs that have poor bioavailability are potential candidates to be formulated as floating drug delivery systems, thereby maximizing their absorption.
5- FDDS improves patient’s compliance by reducing dosing frequency.
6- Better therapeutic effect achieved from short half-life drugs.
7- Because